Brought to you by 
Grail and Cirina merge
Jun 2017
Executive Summary
Molecular diagnostics firms Grail Inc. and Cirina Ltd. agreed to combine in a deal that gives two-year-old Grail greater product potential and access to the noninvasive molecular diagnostics market in Asia. Financial details were not disclosed.
Deal Industry
- Biotechnology
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Intra-Biotech Deal
- Full Acquisition
- Acquisition of Private Biotech
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Grail and Cirina merge
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice